1. NICE CKS: Chlamydia - uncomplicated genital June 2006
2. Public Health England PHE, 2015
3. British Association for Sexual Health and HIV (BASHH) 2015 UK national guideline for the management of infection with Chlamydia trachomatis, [BASHH, 2015]
4. Scottish Intercollegiate Guidelines Network (SIGN) guideline Management of genital Chlamydia trachomatis infection [SIGN, 2009].
5. Royal College of General Practitioners (RCGP) guideline Sexually Transmitted Infections in Primary Care [RCGP, 2013].
6. Health Protection Agency guideline on Diagnosis of Chlamydia trachomatis, Quick Reference Guide for General Practices [HPA, 2008].
7. BNF 71 (2016) British National Formulary.
8. Schembri G, Schober P. Risk factors for chlamydial infection in chlamydia contacts: a questionnaire-based study. J Fam Plann Reprod Health Care 2011; 37(1): 10-16.
9. Haggerty CL, Gottlieb SL, Taylor BD et al. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis 2010 Jun 15; 201 Suppl 2: S134-55.
10. Bezold G, Politch JA, Kiviat NB, et al. Prevalence of sexually transmissible pathogens in semen from asymptomatic male infertility patients with and without leukocytospermia. Fertil Steril 2007; 87: 1087–1097.
11. Joki-Korpela P, Sahrakorpi N, Halttunen M, et al. The role of Chlamydia trachomatis infection in male infertility. Fertil Steril 2009; 91(4 Suppl): 1448–1450.
12. Lau Cy, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis 2002;29(9):497-502.